522 related articles for article (PubMed ID: 33126867)
1. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
[TBL] [Abstract][Full Text] [Related]
2. Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).
Grosu AL; Frings L; Bentsalo I; Oehlke O; Brenner F; Bilger A; Fennell JT; Rothe T; Schneider-Fuchs S; Graf E; Schmoor C; Beck J; Becker G; Bock M; Egger K; Urbach H; Lahmann C; Popp I
BMC Cancer; 2020 Jun; 20(1):532. PubMed ID: 32513138
[TBL] [Abstract][Full Text] [Related]
3. Quality assurance analysis of hippocampal avoidance in a melanoma whole brain radiotherapy randomized trial shows good compliance.
Martinage G; Hong AM; Fay M; Thachil T; Roos D; Williams N; Lo S; Fogarty G
Radiat Oncol; 2018 Jul; 13(1):132. PubMed ID: 30029684
[TBL] [Abstract][Full Text] [Related]
4. Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.
Popp I; Rau S; Hintz M; Schneider J; Bilger A; Fennell JT; Heiland DH; Rothe T; Egger K; Nieder C; Urbach H; Grosu AL
Cancer; 2020 Jun; 126(11):2694-2703. PubMed ID: 32142171
[TBL] [Abstract][Full Text] [Related]
5. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
[TBL] [Abstract][Full Text] [Related]
6. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases.
Lebow ES; Hwang WL; Zieminski S; Wang Y; Niemierko A; Mehan WA; Oh KS; Khandekar M; Willers H; Shih HA
J Neurooncol; 2020 May; 148(1):81-88. PubMed ID: 32307637
[TBL] [Abstract][Full Text] [Related]
7. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
Tsao MN; Lloyd N; Wong RK; Chow E; Rakovitch E; Laperriere N; Xu W; Sahgal A
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003869. PubMed ID: 22513917
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal Sparing Whole Brain Radiotherapy and Integrated Simultaneous Boost vs Stereotactic Radiosurgery Boost: A Comparative Dosimetric Planning Study.
Cheah SK; Matthews T; Teh BS
Asian Pac J Cancer Prev; 2016; 17(9):4233-4235. PubMed ID: 27797223
[TBL] [Abstract][Full Text] [Related]
9. Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost-tutorial and efficacy of complete directional hippocampal blocking.
Popp I; Grosu AL; Fennell JT; Fischer M; Baltas D; Wiehle R
Strahlenther Onkol; 2022 Jun; 198(6):537-546. PubMed ID: 35357511
[TBL] [Abstract][Full Text] [Related]
10. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.
Tsao MN; Xu W; Wong RK; Lloyd N; Laperriere N; Sahgal A; Rakovitch E; Chow E
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003869. PubMed ID: 29365347
[TBL] [Abstract][Full Text] [Related]
11. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial.
Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP
J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290
[TBL] [Abstract][Full Text] [Related]
12. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
[TBL] [Abstract][Full Text] [Related]
13. Sparing the hippocampus and the hypothalamic- pituitary region during whole brain radiotherapy: a volumetric modulated arc therapy planning study.
Mehta P; Janssen S; Fahlbusch FB; Schmid SM; Gebauer J; Cremers F; Ziemann C; Tartz M; Rades D
BMC Cancer; 2020 Jun; 20(1):610. PubMed ID: 32605648
[TBL] [Abstract][Full Text] [Related]
14. Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance.
Kim Y; Kim SH; Lee JH; Kang DG
Cancer Res Treat; 2019 Apr; 51(2):568-575. PubMed ID: 30011983
[TBL] [Abstract][Full Text] [Related]
15. Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions.
Wang X; Chen J; Lei Z; Chen H; Zhang Y; Liu G; Li S; Zheng Z; Wang H
BMC Cancer; 2023 Aug; 23(1):796. PubMed ID: 37620791
[TBL] [Abstract][Full Text] [Related]
16. Whole brain radiotherapy for the treatment of multiple brain metastases.
Tsao MN; Lloyd N; Wong R; Chow E; Rakovitch E; Laperriere N
Cochrane Database Syst Rev; 2006 Jul; (3):CD003869. PubMed ID: 16856022
[TBL] [Abstract][Full Text] [Related]
17. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
18. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer.
Westover KD; Mendel JT; Dan T; Kumar K; Gao A; Pulipparacharuv S; Iyengar P; Nedzi L; Hannan R; Anderson J; Choe KS; Jiang W; Abdulrahman R; Rahimi A; Folkert M; Laine A; Presley C; Cullum CM; Choy H; Ahn C; Timmerman R
Neuro Oncol; 2020 Dec; 22(12):1831-1839. PubMed ID: 32347302
[TBL] [Abstract][Full Text] [Related]
20. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
Brown PD; Jaeckle K; Ballman KV; Farace E; Cerhan JH; Anderson SK; Carrero XW; Barker FG; Deming R; Burri SH; Ménard C; Chung C; Stieber VW; Pollock BE; Galanis E; Buckner JC; Asher AL
JAMA; 2016 Jul; 316(4):401-409. PubMed ID: 27458945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
